Heart Attack
Manoj Lal Karwa
Mahsa Kanzali
Tannaz Iranpour Boroujeni
Ester Ilyayeva
Joseph J. Hong
Edwin C.W. Ho
Dr. Hos' clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.
Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings.
<p>Edwin Ho, MD, is Co-Director of the Heart Valve/Structural Heart Center at Montefiore. His clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.</p><p>In 2010, Dr. Ho received his Doctor of Medicine from the University of Toronto in Toronto, Ontario. He continued at the institution for his postdoctoral training with a three-year residency in general internal medicine from 2010 to 2013, followed by a three-year residency in adult cardiology, which he completed in 2016. He then pursued a clinical fellowship in echocardiography, interventional echocardiography and valvular heart disease at St. Michael’s Hospital in Toronto. After completing this in 2017, he continued his postdoctoral training at the University Hospital of Zurich in Switzerland, completing a clinical fellowship in interventional echocardiography and valvular heart disease in 2017 to 2019.</p><p>Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings. He has been an invited manuscript reviewer for <em>Circulation: Cardiovascular Imaging</em> and <em>Cardiovascular Medicine</em>.</p>
Joseph B. Helft
Nils A. Guttenplan
<p>Dr. Guttenplan is committed to improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. All contemporary approaches including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices are drawn upon to achieve this aim.</p>
<p>Dr. Guttenplan is the principle investigator at Montefiore in an outcomes study of a left ventricular quadrapolar pacing lead. During the study he as adapted the use of an interventional snare technique. This approach has allowed for successful left ventricular lead placement, that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-investigator in the division's ablation studies.</p>
<p>Nils A. Guttenplan, MD, is an Attending Physician in the Cardiology Department at Montefiore. His clinical focus is improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. He has an interest in all contemporary approaches to achieve this aim, including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices. Dr. Guttenplan joined the Montefiore team in 2018.</p><p>Dr. Guttenplan attended New York Medical College where he received his Doctor of Medicine. In 2004, Dr. Guttenplan completed a residency in Internal Medicine at St. Vincent?s Medical Center. He completed a fellowship in Cardiovascular Disease at our Albert Einstein College of Medicine, followed by a fellowship in Clinical Cardiac Electrophysiology at New York University.</p><p>Dr. Guttenplan is the Principal Investigator in a study on left ventricular quadripolar pacing lead. During the study, he has developed the use of an interventional snare technique that has allowed for successful left ventricular lead placement that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-Investigator in the division's ablation studies. His work has been published in numerous peer-reviewed journals.</p>
Jay N. Gross
<p>Dr. Gross specializes in complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p>
<p>Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p>
<p>Jay N. Gross, MD, serves as an Attending Physician and Director of the Implantable Electrical Devices Service at Montefiore, as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/2274/jay-gross/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p><p>After graduating from our Albert Einstein College of Medicine, and completing his residency at Montefiore in Internal Medicine, Dr. Gross continued on to complete a cardiology fellowship at Montefiore. <br /><br />Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate-modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p><p>Recent clinical highlights for Dr. Gross include: the first reported cases of implantation of subcutaneous ICDs in heart transplant patients, simultaneous lead extraction and debulking of large vegetations in patients with endocarditis, concomitant lead extraction and implantation of leadless pacemakers, and care for of congenital heart patients who require both transvenously implanted devices and subcutaneous ICDs.</p><p>Dr. Gross is board certified in Internal Medicine, Cardiology, and Cardiovascular Electrophysiology as well as a Certified Cardiac Device Specialist (CCDS) by the International Board of Heart Rhythm Examiners. He is a Fellow of the American College of Cardiology and a member of the Heart Rhythm Society. Dr. Gross has served on the Writing Committee of the International Board of Heart Rhythm Board of Examiners for over two decades and now serves on its board of directors. He has been named to the Castle Connolly/NY Magazine List of Best EP Doctors in New York for the past two years.</p>